Antisense Nucleic Acids

Patent No. EP3018211 (titled "Antisense Nucleic Acids") was filed by National Center OF Neurology And Psychiatry on Aug 31, 2011. The application was issued on Aug 7, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEMay 7, 2020CARPMAELS & RANSFORD
SAREPTA THERAPEUTICSMay 6, 2020D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3018211

NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
Application Number
EP15199455A
Filing Date
Aug 31, 2011
Status
Revoked
May 13, 2022
Publication Date
Aug 7, 2019